Citation:Bleicher ID, Rossin EJ, Vavvas DG. Reevaluating the Risk of Serious Adverse Events of Carbonic Anhydrase Inhibitors. JAMA Ophthalmol 2022;140(7):745-746.Download CitationPubMed DOI BibTex Tagged XML Date Published:2022 Jul 01See also: Glaucoma, July 2022, All, 2022Last updated on 07/31/2022 PubMedDOI
